EcoDrugPlus

60s Ribosomal Protein L14-Like

Ensembl ID : ENSNBRG00000020910
Gene Symbol: LOC102799232
3 Cross references
305 Possible Orthologues:

60s Ribosomal Protein L15-Like

Ensembl ID : ENSNBRG00000006570
Gene Symbol: LOC102788215
4 Cross references
175 Possible Orthologues:

60s Ribosomal Protein L15-Like

Ensembl ID : ENSNBRG00000000191
Gene Symbol: LOC102786454
3 Cross references
77 Possible Orthologues:

60s Ribosomal Protein L17-Like

Ensembl ID : ENSNBRG00000006026
Gene Symbol: LOC102794849
3 Cross references
710 Possible Orthologues:

60s Ribosomal Protein L18-Like

Ensembl ID : ENSNBRG00000002581
Gene Symbol: LOC102789938
3 Cross references
379 Possible Orthologues:

60s Ribosomal Protein L18a-Like

Ensembl ID : ENSNBRG00000017030
Gene Symbol: LOC102776055
3 Cross references
367 Possible Orthologues:

60s Ribosomal Protein L19-Like

Ensembl ID : ENSNBRG00000020187
Gene Symbol: LOC102799808
3 Cross references
321 Possible Orthologues:

60s Ribosomal Protein L19-Like

Ensembl ID : ENSNBRG00000016543
Gene Symbol: LOC102780598
4 Cross references
338 Possible Orthologues:

60s Ribosomal Protein L21-Like

Ensembl ID : ENSNBRG00000023147
Gene Symbol: LOC102785127
3 Cross references
784 Possible Orthologues:

60s Ribosomal Protein L22-Like

Ensembl ID : ENSNBRG00000005163
Gene Symbol: LOC102779685
3 Cross references
208 Possible Orthologues:

60s Ribosomal Protein L23a-Like

Ensembl ID : ENSNBRG00000007719
Gene Symbol: LOC102794729
3 Cross references
210 Possible Orthologues:

60s Ribosomal Protein L24-Like

Ensembl ID : ENSNBRG00000005337
Gene Symbol: LOC102799965
3 Cross references
318 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).